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Summary
 
Epidermal Langerhans cells (LC) are immature dendritic cells (DC) located in close proximity
to the site of inoculation of infectious 
 
Leishmania major 
 
metacyclic promastigotes by sand flies.
Using LC-like DC expanded from C57BL/6 fetal skin, we characterized interactions involving
several developmental stages of 
 
Leishmania 
 
and DC. We confirmed that 
 
L
 
.
 
 major
 
 amastigotes,
but not promastigotes, efficiently entered LC-like DC. Parasite internalization was associated
with activation manifested by upregulation of major histocompatibility complex (MHC) class I
and II surface antigens, increased expression of costimulatory molecules (CD40, CD54, CD80,
and CD86), and interleukin (IL)-12 p40 release within 18 h. 
 
L
 
.
 
 major
 
–induced IL-12 p70 re-
lease by DC required interferon 
 
g
 
 and prolonged (72 h) incubation. In contrast, infection of
inflammatory macrophages (M
 
f
 
) with
 
 
 
amastigotes or promastigotes did not lead to significant
changes in surface antigen expression or cytokine production. These results suggest that skin
M
 
f
 
 and DC are infected sequentially in cutaneous leishmaniasis and that they play distinct
roles in the inflammatory and immune response initiated by 
 
L
 
.
 
 major
 
. M
 
f
 
 capture organisms
near the site of inoculation early in the course of infection after establishment of cellular immu-
nity, and kill amastigotes but probably do not actively participate in T cell priming. In contrast,
skin DC are induced to express increased amounts of MHC antigens and costimulatory mole-
cules and to release cytokines (including IL-12 p70) by exposure to 
 
L
 
.
 
 major
 
 amastigotes that
ultimately accumulate in lesional tissue, and thus very likely initiate protective T helper cell
type 1 immunity.
Key words: Langerhans cell • dendritic cell • 
 
Leishmania major 
 
•
 
 
 
T helper cell type 1/T helper 
cell type 2 immune response • interleukin 12
evelopment of T cell–mediated immunity against for-
eign Ag necessitates prior Ag-nonspecific triggering
of APCs. With the recognition that dendritic cells (DC) are
uniquely able to initiate responses in naive T cells and that
DC also participate in Th cell education (for a review, see
references 1 and 2), considerable effort has been directed
towards identifying DC agonists and elucidating mecha-
nisms that mediate DC activation. We have recently iden-
tified culture conditions that allow the expansion of epider-
mal Langerhans cell (LC)-like immature DC from murine
fetal skin (fetal skin–derived DC [FSDDC]; reference 3)
and have begun to characterize the response of FSDDC to
a variety of agonists (4, 5).
To study LC/DC–pathogen interactions and mecha-
nisms responsible for pathogen-dependent DC activation,
we initiated experiments with FSDDC and 
 
Leishmania ma-
jor
 
. This experimental system was chosen because 
 
L
 
.
 
 major
 
infection in mice is a well-established model for human cu-
taneous leishmaniasis (for a review, see reference 6), and
previous studies implicated LC as important participants in
the initiation phase of immune responses to 
 
Leishmania
 
 in
vivo (7–9). Prior in vitro studies of LC–
 
L
 
.
 
 major
 
 interac-
tions have been hampered by technical difficulties associ-
ated with isolating keratinocyte-free LC and the spontane-
ous activation that results from removing LC from their
epidermal microenvironment.
In this study, we have taken advantage of the relatively
stable immature phenotype of FSDDC (4, 5) to assess the
DC-activating potential of the two developmental stages of
 
L
 
.
 
 major 
 
that might interact with skin DC in the setting of
cutaneous leishmaniasis. We also evaluated cytokines pro-
duced by FSDDC and inflammatory macrophages (M
 
f
 
) in
 
D
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response to 
 
L
 
.
 
 major
 
 because cytokine-dependent Th edu-
cation ultimately determines the outcome of infection (for
a review, see references 6, and 10–12). We observed that
FSDDC preferentially ingested and were activated by 
 
L
 
.
 
major
 
 amastigotes, and that FSDDC activation resulted in
IL-12 release. Although M
 
f
 
 readily ingested amastigotes
(as well as promastigotes), they were not activated by infec-
tion. These data suggest that M
 
f 
 
and DC are sequentially
parasitized in cutaneous leishmaniasis, and that skin DC,
rather than M
 
f
 
, are responsible for Th priming and the
initiation of Th education in this disease.
 
Materials and Methods
 
Propagation of FSDDC.
 
Immature FSDDC were generated as
described previously (3). In brief, fetal skin cells from day 16
C57BL/6 mice were cultured in GM-CSF– and M-CSF–supple-
mented media and, after 
 
z
 
2 wk, DC aggregates were isolated by
1 
 
g
 
 sedimentation. DC aggregates were dissociated in trypsin/
EDTA (0.25%/0.1 mM; reference 3) as necessary to allow accu-
rate determination of cell numbers.
 
Isolation of Inflammatory M
 
f
 
.
 
Inflammatory C57BL/6 tissue
M
 
f 
 
were elicited by subcutaneous injection of polyacrylamide
beads (13). Cells infiltrating the resulting nonimmune granulomas
were harvested after 3–4 d, cells were separated from beads by fil-
tering through 70 
 
m
 
m nylon mesh, and M
 
f 
 
were enriched by
plastic adherence.
 
Propagation and Isolation of L. major. L
 
.
 
 major
 
 clone V1 (MHOM/
IL/80/Friedlin) was cultured and different developmental stages
were prepared as described (13). Infectious metacyclic promasti-
gotes were isolated from stationary cultures by negative selection
using peanut agglutinin. Amastigotes were prepared from homog-
enates of tissue derived from BALB/c footpad lesions via differ-
ential centrifugation and were used immediately or suspended in
DMEM/10% fetal bovine serum (FBS)/7.5% DMSO and stored
in liquid nitrogen. Isolated parasites were opsonized with 5% nor-
mal mouse serum before infection. Levels of LPS in parasite stock
preparations were below the limit of detection (
 
,
 
0.1 endotoxin
units/ml [LAL-test; BioWhittaker, Inc., Walkersville, MD]). Par-
asites were diluted 1:100 before use.
 
Coculture Experiments with L. major and FSDDC or M
 
f
 
.
 
FSDDC
aggregates or M
 
f 
 
were subcultured in their basal media (5% FBS
containing GM-CSF– and M-CSF–supplemented RPMI 1640
[3] and complete DMEM/10% FBS [13], respectively) in 24-well
plates at 2 
 
3 
 
10
 
5
 
 cells in 1 ml/well (or 10
 
6
 
 cells/well for determi-
nation of IL-12 p70 levels). 
 
L
 
.
 
 major
 
 parasites (two to three organ-
isms/cell) or 
 
Escherichia coli 
 
LPS (100 ng/ml; provided by Dr.
Stephanie Vogel, Uniformed Services University of the Health
Sciences, Bethesda, MD), IFN-
 
g
 
 (1,000 U/ml; Genzyme Corp.,
Cambridge, MA), and anti-CD40 (HM40-3, 10 
 
m
 
g/ml; Phar-
Mingen, San Diego, CA) were added as indicated.
 
Microscopy.
 
Morphologic changes in FSDDC aggregates in
the coculture experiments were documented after 18 h using a
video-linked inverted phase microscope (Eclipse TE 300; Nikon,
Inc., Melville, NY). Parasite internalization was quantitated in
DiffQuick-stained cytospin preparations using light microscopy.
FSDDC aggregates were completely dissociated in calcium- and
magnesium-free HBSS containing 1 mM EDTA (30 min at
37
 
8
 
C) before cytocentrifugation.
 
Antibodies and Flow Cytometry.
 
Anti-CD16/CD32 (2.4G2) was
provided by Julie Titus (National Cancer Institute, Bethesda).
Anti–H-2D
 
b
 
 (28-14-8), anti–I-A
 
b
 
 (2G9), anti-CD40 (3/23), anti-
CD54 (3E2), anti-CD80 (1G10), and anti-CD86 (GL1) were
purchased from PharMingen as biotin- or PE-modified mAbs.
PE-streptavidin was obtained from Tago Inc. (Burlingame, CA).
Cells were stained for surface Ag expression as described previ-
ously (3). Stained and paraformaldehyde (1% in PBS)-fixed cells
were analyzed using a FACScan
 
Ò
 
 flow cytometer equipped with
CellQuest software (Becton Dickinson, Mountain View, CA).
 
Quantitation of Cytokine Release.
 
Cytokine release into 18-
and 72-h FSDDC and M
 
f 
 
supernatants was measured using
ELISA kits specific for IL-1
 
a
 
, IL-12 (p70), and TNF-
 
a 
 
(Gen-
zyme Corp.), or IL-1
 
b
 
, IL-4, IL-6, IL-10, IL-12 (p40), and IFN-
 
g
 
(Biosource International, Camarillo, CA). Supernatants were
concentrated approximately fivefold using microconcentrators
(30K Microcon; Amicon, Inc., Beverly, MA) before determina-
tion of IL-12 p70. Statistical analysis was performed using the
Wilcoxon signed rank test.
 
Results
 
FSDDC Internalized L. major Amastigotes, but not Metacy-
clic Promastigotes.
 
FSDDC were incubated with the differ-
ent forms of serum-opsonized 
 
L
 
.
 
 major
 
, and cell–parasite
interactions were studied by light microscopic examination
of cytospin preparations. 18 h after amastigote addition, 36 
 
6
 
8% (
 
n
 
 
 
5
 
 10) of the FSDDC were infected, and each in-
fected cell contained up to six parasites (Fig. 1 
 
A
 
). In con-
trast, coincubation of FSDDC with promastigotes led to
parasite attachment (Fig. 1 
 
B
 
), but only very low infection
rates (7 
 
6 
 
3%,
 
 n 
 
5
 
 4).
Figure 1. L. major amastigotes preferentially infect FSDDC and induce
dissociation of FSDDC aggregates. C57BL/6 FSDDC were incubated
with L. major amastigotes (A and C) or metacyclic promastigotes (B and
D) for 18 h. (A and B) After complete dissociation of aggregates in
EDTA, cytospins were prepared and stained with DiffQuick, and DC–
parasite interactions were evaluated. (C and D) The morphology of FS-
DDC aggregates was assessed by phase–contrast photomicroscopy. Rep-
resentative data from one of four experiments are shown. 
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L. major Amastigotes Activate FSDDC.
 
E-cadherin–medi-
ated adhesion within aggregates of immature FSDDC can
be viewed as a correlate of E-cadherin–mediated adhesion
of LC to keratinocytes in epidermis (3, 14). Previous stud-
ies demonstrated that treatment of FSDDC with LPS or
proinflammatory cytokines led to loss of adhesion within
FSDDC aggregates and DC maturation (increased expres-
sion of MHC Ag and costimulatory molecules and en-
hanced APC activity [4]). Coincubation of FSDDC with
 
L
 
.
 
 major
 
 amastigotes for 18 h also induced dissociation of
FSDDC aggregates into single, highly dendritic cells (Fig. 1
 
C
 
). Although promastigotes adhered to FSDDC (Fig. 1 B),
attachment was not accompanied by morphologic evidence
of activation (Fig. 1 D).
Analysis of surface Ag expression using flow cytometry
confirmed that L. major amastigotes selectively induced
FSDDC activation and maturation. Amastigote infection of
FSDDC led to upregulation of MHC class I, class II, CD40,
CD54 (intracellular adhesion molecule 1 [ICAM-1]), CD80
(B7.1), and CD86 (B7.2) analogous to that observed after ad-
dition of the known DC activators LPS and IFN-g (Fig. 2).
In contrast, coincubation of FSDDC with L. major promas-
tigotes did not affect levels of the activation markers studied.
Failure of L. major to Activate Inflammatory Tissue Mf.
Both infectious metacyclic promastigotes and tissue amasti-
gotes of L. major are efficiently internalized by Mf (13). To
determine if skin DC and Mf were differentially activated
by exposure to Leishmania, the expression of relevant sur-
face Ag by infected Mf was quantitated. In the absence of
agonists, infiltrating tissue Mf expressed low levels of
MHC class II, CD40, CD54, and CD86 (Fig. 3), as well as
MHC class I and CD80 (data not shown), consistent with
their derivation from nonimmune granulomas. Although
incubation of Mf with L. major amastigotes or metacyclic
promastigotes resulted in frequent infection (infection rates
of 62 6 12% [n 5 4] and 53 6 8% [n 5 2], respectively)
within 18 h, neither life-cycle stage led to upregulation of
activation markers (Fig. 3).
Amastigote-infected FSDDC Release IL-12. The outcome
of encounters between Ag-bearing APCs and naive T cells
depends, in part, on the nature of the cytokines released lo-
cally by APCs. This is particularly relevant in leishmaniasis
because development of Th1-predominant protective immu-
nity is clearly dependent on production of IL-12 (for a
review, see references 6 and 11). Thus, we identified and
quantitated cytokines released by Leishmania-infected FSDDC
and, for comparison, cytokines released by infected Mf.
Relative to untreated FSDDC, amastigote-infected FSDDC
released z12-fold more IL-12 p40 (P , 0.05, n 5 9) and
increased amounts of TNF-a (P , 0.05, n 5 9) into super-
natants (see Table 1), whereas incubation of FSDDC with
Figure 2. L. major amastigotes induce up-
regulation of FSDDC MHC class I, class II,
and costimulatory molecule expression. L.
major amastigotes, metacyclic promastigotes,
or LPS (100 ng/ml) and IFN-g (1,000 U/ml)
were added to FSDDC, and effects on surface
Ag expression were assessed using flow cy-
tometry 18 h later. Residual aggregates were
dissociated with EDTA before analysis.
Shaded areas, mAbs of interest; solid lines, iso-
type controls (n 5 4).
Figure 3. L. major does not activate inflammatory Mf. Polyacrylamide
bead–elicited tissue macrophages were infected with L. major amastigotes
or metacyclic promastigotes, or stimulated with LPS (100 ng/ml) and
IFN-g (1,000 U/ml) for 18 h. MHC class II, CD40, CD54, and CD86
levels were analyzed after 18 h using flow cytometry. Shaded areas, mAbs
of interest; solid lines, isotype control (n 5 4).1550 Activation and IL-12 Release by L. major–infected Skin–derived Dendritic Cells
promastigotes did not stimulate cytokine production. Small
amounts of IL-1a, IL-1b, and IL-6 were also released by
FSDDC (Table 1, and data not shown), but production of
these cytokines was not augmented by infection with
amastigotes. IL-4, IL-10, IL-12 p70, and IFN-g were not
detected in 18-h FSDDC supernatants (data not shown).
Interestingly, prior infection of FSDDC with amastigotes
did not inhibit IL-12 release induced by relatively high
concentrations of LPS and IFN-g (Table 1). Consistent
with previous reports (15), bioactive IL-12 (p70) was de-
tected only in 72-h supernatants of FSDDC (Table 2).
Amastigote-induced FSDDC IL-12 p70 release also re-
quired addition of IFN-g. Note that similar amounts of
IL-12 p70 were released by amastigotes plus IFN-g and
maximally stimulated LPS plus IFN-g plus anti-CD40–
treated FSDDC.
These results contrast with those obtained with Mf. In-
fection of nonimmune tissue Mf with L. major did not in-
duce significantly increased production of IL-12 or other
cytokines (Table 1). In addition, LPS plus IFN-g–induced
IL-12 release by Mf was inhibited by infection with
amastigotes before stimulation. These findings confirm pre-
vious observations made with Mf infected with metacyclic
promastigotes or amastigotes (6, 13, 16, 17), and highlight
the differential effects of Leishmania on DC and Mf.
Discussion
Cutaneous leishmaniasis is initiated by inoculation of
small numbers of L. major metacyclic promastigotes into the
dermis (for a review, see references 6 and 18). Although
Mf ingest promastigotes, they are not activated and are
rendered selectively unable to produce the Th1-promoting
cytokine IL-12 in response to inflammatory mediators (ref-
erences 6, 13, and 16, and this study). In addition, the evi-
dence that Leishmania-infected Mf migrate to regional
lymph nodes and trigger responses in naive T cells is not
compelling (8). Thus, although dermal Mf represent the
initial site of parasite proliferation after epicutaneous inocu-
lation and IFN-g–activated Mf are ultimately responsible
for the destruction of organisms (6, 18), Mf may not play a
role in the induction of anti-Leishmania immunity.
Table 1. Cytokine Release by L. major–infected FSDDC and Inflammatory Mf
Additions
Cytokines analyzed
IL-12 (p40) IL-12 (p70) TNF-a IL-6
FSDDC
None 34 6 13 ,5 ,35 123 6 67
Metacyclic promastigotes 28 6 17 ,5 ,35 163 6 119
Amastigotes 346 6 134‡ ,5 112 6 43‡ 178 6 107
LPS 1 IFN-g 1,226 6 507‡ ,5 342 6 130‡ 1,599 6 737‡
Amastigotes 1 LPS 1 IFN-g* 2,323 6 1,584‡ ,5 503 6 56‡ 969 6 258‡
Mf
None 43 6 11 ,5 ,35 1,045 6 453
Metacyclic promastigotes 27 6 13 ,5 ,35 868 6 868
Amastigotes 44 6 29 ,5 251 6 251 701 6 481
LPS 1 IFN-g 3,610 6 1,648 686 6 450 5,447 6 425 .20,000
Amastigotes 1 LPS 1 IFN-g 1,028 6 595 45 6 45 2,949 6 1,561 11,585 6 4,902
FSDDC aggregates (n 5 9) or Mf (n 5 4) were incubated with L. major promastigotes or amastigotes (two to three organisms/cell) or with LPS
(100 ng/ml) plus IFN-g (1,000 U/ml) as indicated. Cytokine levels in 18-h supernatants were determined by ELISA. Values represent pg/ml of cy-
tokine produced by 2 3 105 cells/ml in 18 h (mean 6 SEM).
*LPS and IFN-g were added 3 h after amastigotes.
‡P , 0.05 compared with untreated control.
Table 2. Release of Bioactive IL-12 (p70) by
L. major–infected FSDDC
Additions IL-12 (p70)
None ,5
IFN-g, 5
Amastigotes ,5
Amastigotes 1 IFN-g 56 6 9*
LPS 1 IFN-g 1 anti-CD40 86 6 7*
FSDDC aggregates (n 5 3) were incubated with L. major amastigotes
(two to three organisms/cell) or with LPS (100 ng/ml), IFN-g (1,000
U/ml), and anti-CD40 (10 mg/ml) as indicated. Cytokine levels in
fivefold concentrated 72-h supernatants (106 FSDDC/ml) were deter-
mined by ELISA (pg/ml; mean 6 SEM).
*P , 0.05 compared with untreated control.1551 von Stebut et al. Brief Definitive Report
The results of this and previous studies suggest that DC
rather than Mf are responsible for T cell priming in leishma-
niasis. Because the L. major life form that is inoculated into
skin does not parasitize immature DC (references 19 and 20,
and this study), it seems likely that LC/DC infection occurs
subsequent to amastigote release by Mf. Exposure of FS-
DDC to amastigotes led to upregulation of MHC and co-
stimulatory molecules and loss of E-cadherin–mediated adhe-
sion within aggregates. The former observation is consistent
with earlier results which indicated that amastigotes induced a
transient increase in MHC class II biosynthesis in LC (21).
The latter finding demonstrates that L. major amastigote–
induced activation of FSDDC is associated with downregula-
tion of E-cadherin expression and/or function as might be
expected before mobilization of LC from epidermis to lymph
nodes (4, 22). Although coincubation with amastigotes did
not lead to infection of the entire FSDDC population, MHC
and costimulatory molecules were upregulated on almost all
cells. This may reflect a bystander effect (e.g., activation of
uninfected DC by TNF-a release by infected cells [3]) or
effects of organism fragments/subcellular fractions of parasites
that are not visualized by light microscopy.
IL-12 plays an important role in the immunophysiology
of experimental leishmaniasis and is required for the devel-
opment of protective Th1-predominant immunity (for a
review, see reference 6). In addition to directly facilitating
Th1 education, IL-12 activates NK cells to become effec-
tors and produce IFN-g (23), which may also promote
Th1 development and/or augment Mf leishmaniacidal ac-
tivity. Because Leishmania-infected tissue Mf do not re-
lease IL-12 spontaneously or in response to potent stimuli
(references 6, 13, 16, and 17, and this study), it is unlikely
that Mf are the primary source of IL-12 in lesional tissue.
Recent studies indicate that systemic administration of
Toxoplasma gondii extracts (24) or Leishmania donovani
amastigotes (25) results in rapid IL-12 p40 accumulation in
DC in lymphoid tissue, but not in Mf. These observations
localize IL-12 production to the APCs and the microenvi-
ronment that are thought to be critical for T cell priming.
Our results indicate that parasitized DC are a likely source
of IL-12 in leishmaniasis, and demonstrate that amastigotes
directly stimulate IL-12 production by skin DC. In addi-
tion to inducing IL-12 release, our data also indicate that L.
major amastigotes induce DC maturation. We hypothesize
that local activation of skin DC by Leishmania, mobilization
of skin DC, and localization of Ag-bearing, IL-12–produc-
ing mature DC in regional lymph nodes is required for de-
velopment of protective immunity. The delayed appear-
ance of IL-12 p40 transcripts in lymph nodes draining
murine skin inoculated with L. major (6) has been attrib-
uted to dissemination of amastigotes from skin to lymph
nodes followed by IL-12 synthesis within Mf. An alterna-
tive interpretation is that parasites are conveyed to lymph
nodes by skin-derived DC, and that IL-12 is produced
within infected DC. The scenario we propose is also consis-
tent with previous data indicating that infected DC can be
recovered from lymph nodes that drain murine skin inocu-
lated with L. major, and that L. major–infected LC can ini-
tiate primary anti-Leishmania responses in T cells after injec-
tion into naive mice whereas infected Mf cannot (8, 9, 26).
We envision that skin DC play a particularly important
role as transporters of parasites/Ag to lymph nodes in cuta-
neous leishmaniasis initiated by small numbers of parasites
(e.g., numbers of parasites comparable to those introduced
by sand flies), where extracutaneous dissemination occurs
only after significant proliferation of Leishmania in the der-
mis. The observation that development of protective im-
munity in naturally acquired infections in people (27) and
in C57BL/6 mice inoculated with small numbers of meta-
cyclic promastigotes (D.L. Sacks, unpublished observations)
is delayed relative to that which occurs after administration
of standard inocula suggests the existence of a threshold re-
quirement that must be satisfied before priming of naive T
cells can occur. One possibility is that recruitment of epi-
dermal LC or dermal DC into sites of inoculation requires
elaboration of proinflammatory cytokines (e.g., IL-1 or
TNF-a) or chemokines (16, 28), which are released only
after a significant parasite load accumulates. Alternatively
(or in addition), priming may require that relatively large
numbers of extracellular amastigotes are available to acti-
vate resident skin DC. The latter possibility would suggest
that parasites that are effectively sequestered within Mf in
the early stages of infection would not initiate priming and
also might not lead to a dramatic inflammatory response.
Additional experiments will be required to distinguish be-
tween these, and other, potential explanations.
Delineation of the role that skin DC play in T cell prim-
ing in cutaneous leishmaniasis is important for several rea-
sons. First, leishmaniasis is a significant world health problem
for which no effective vaccine exists. Development of a use-
ful vaccine will require identification of adjuvants that elicit
protective responses as well as relevant Ag. Because DC are
likely to be involved in Th1 education, DC agonists may be
potent adjuvants. Second, it is interesting that DC and Mf
are differentially activated by L. major. This suggests that
Leishmania may initiate immune responses via mechanisms
that are distinct from those activated by other parasites (e.g.,
the potent Mf activators T. gondii (29) and Listeria monocy-
togenes [30]). Elucidation of these mechanisms will further our
understanding of the roles DC and Mf play in the patho-
physiology of various parasitic diseases and may also improve
our ability to prevent or treat these common infections.
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